Patent intelligence · WO
WO 2020095183
COMBINAISON POUR LE TRAITEMENT DU CANCER
COMBINAISON POUR LE TRAITEMENT DU CANCER
Patent details — WO 2020095183
- Jurisdiction
- WO
- Status
- granted
- Grant date
- May 14, 2020
- Expiration
- May 9, 2040
- Applicant
- PFIZER [US]
- CPC classes
- A61K 31/ 4166 A I, A61K 38/ 08 A I, A61K 39/ 00 A I, A61K 45/ 06 A I
Quick answer
WO 2020095183 (COMBINAISON POUR LE TRAITEMENT DU CANCER) is held by PFIZER [US]. Status: granted. Granted May 14, 2020. Expires May 9, 2040 (14 years remaining) — relevant for patent-cliff and LOE planning.
Key facts
- Applicant
- PFIZER [US]
- Grant date
- Expiration
- Claims
- —
- CPC classes
- A61K 31/ 4166 A I, A61K 38/ 08 A I, A61K 39/ 00 A I, A61K 45/ 06 A I, A61K/314166, A61K/315025
More from PFIZER [US]
Related pharmaceutical patents in our USPTO index.
-
AU 2022206771
Drug conjugates comprising antibodies against Claudin 18.2
granted -
EP 3791896
KOMBINATIONSTHERAPIE MIT ANTIKÖRPERN GEGEN CLAUDIN 18.2 ZUR BEHANDLUNG VON KREBS
granted -
LT 3254695
COMBINATION THERAPY INVOLVING ANTIBODIES AGAINST CLAUDIN 18.2 FOR TREATMENT OF CANCER
granted -
EP 3708579
CLAUDIN-6-SPEZIFISCHE IMMUNREZPTOREN UND T-ZELL-EPITOPE
granted -
HR P20200591
ANTIBODIES SPECIFIC FOR CLAUDIN 6 (CLDN6)
granted -
US 2020199221
ANTIBODIES USEFUL IN CANCER DIAGNOSIS
granted -
US 2019076525
THERAPY INVOLVING ANTIBODIES AGAINST CLAUDIN 18.2 FOR TREATMENT OF CANCER
granted
Frequently asked questions
What is US patent 2020095183?
WO 2020095183 (COMBINAISON POUR LE TRAITEMENT DU CANCER) is held by PFIZER [US]. Status: granted. Granted May 14, 2020. Expires May 9, 2040 (14 years remaining) — relevant for patent-cliff and LOE planning.
Who owns WO 2020095183?
PFIZER [US] is listed as the applicant in USPTO PatentsView records indexed by NovaPharmaNews. We track 25 pharmaceutical patents for this assignee.
When does WO 2020095183 expire?
Our index shows an expiration date of May 9, 2040 (14 years from today). Confirm material dates against USPTO, FDA Orange Book, or qualified counsel before contractual decisions.